Cyclodextrins improving the physicochemical and pharmacological properties of antidepressant drugs: a patent review

Treatment guidelines for depression: Greater emphasis on physical activity is needed

(2017) M. Hallgren et al.   EUROPEAN PSYCHIATRY

Effects of Selective Serotonin Reuptake Inhibitors on Interregional Relation of Serotonin Transporter Availability in Major Depression

(2017) Gregory M. James et al.   Frontiers in Human Neuroscience

A systematic review of yoga for major depressive disorder

(2017) Holger Cramer et al.   JOURNAL OF AFFECTIVE DISORDERS

Host-guest interactions between cyclodextrins and surfactants with functional groups at the end of the hydrophobic tail

(2017) Victoria Isabel Martín et al.   JOURNAL OF COLLOID AND INTERFACE SCIENCE

Interactions between cyclodextrins and cellular components: Towards greener medical applications?

(2016) Loïc Leclercq   Beilstein Journal of Organic Chemistry

Inclusion of terpenes in cyclodextrins: Preparation, characterization and pharmacological approaches

(2016) Pollyana S.S. Lima et al.   CARBOHYDRATE POLYMERS

Cyclodextrins in pharmaceutical formulations II: solubilization, binding constant, and complexation efficiency

(2016) Sunil S. Jambhekar et al.   DRUG DISCOVERY TODAY

Cyclodextrins in pharmaceutical formulations I: structure and physicochemical properties, formation of complexes, and types of complex

(2016) Sunil S. Jambhekar et al.   DRUG DISCOVERY TODAY

A study on negative and depressive symptom prevalence in individuals at ultra-high risk for psychosis

(2016) Marleine Azar et al.   Early Intervention in Psychiatry

Depression as a risk factor for Alzheimer’s disease: Genes, steroids, cytokines and neurogenesis – What do we need to know?

(2016) Joe Herbert et al.   FRONTIERS IN NEUROENDOCRINOLOGY

LARETH-25 and β-CD improve central transitivity and central pharmacological effect of the GLP-2 peptide

(2016) Yusuke Nakao et al.   INTERNATIONAL JOURNAL OF PHARMACEUTICS

Photocatalysis of Volatile Organic Compounds in water: Towards a deeper understanding of the role of cyclodextrins in the photodegradation of toluene over titanium dioxide

(2016) Anthony Lannoy et al.   JOURNAL OF COLLOID AND INTERFACE SCIENCE

The Potential of Cyclodextrins as Novel Active Pharmaceutical Ingredients: A Short Overview

(2016) Massimiliano di Cagno   MOLECULES

PPARα modulation of mesolimbic dopamine transmission rescues depression-related behaviors

(2016) Simona Scheggi et al.   NEUROPHARMACOLOGY

The HDAC inhibitor SAHA improves depressive-like behavior of CRTC1-deficient mice: Possible relevance for treatment-resistant depression

(2016) Elsa M. Meylan et al.   NEUROPHARMACOLOGY

Prevalence of comorbid substance use, anxiety and mood disorders in epidemiological surveys, 1990–2014: A systematic review and meta-analysis

(2015) Harry Man Xiong Lai et al.   DRUG AND ALCOHOL DEPENDENCE

Enhanced analgesic activity by cyclodextrins – a systematic review and meta-analysis

(2015) Renan G Brito et al.   Expert Opinion on Drug Delivery

Recent advances in cyclodextrin delivery techniques

(2015) Hidetoshi Arima et al.   Expert Opinion on Drug Delivery

Cyclodextrins: improving the therapeutic response of analgesic drugs: a patent review

(2015) GB de Oliveira Makson et al.   EXPERT OPINION ON THERAPEUTIC PATENTS

Modulation of muscarinic system with serotonin-norepinephrine reuptake inhibitor antidepressant attenuates depression in mice

(2015) ThakurGurjeet Singh et al.   INDIAN JOURNAL OF PHARMACOLOGY

Involvement of the monoamine system in antidepressant-like properties of 4-(1-phenyl-1h-pyrazol-4-ylmethyl)-piperazine-1-carboxylic acid ethyl ester

(2015) Pablinny Moreira Galdino et al.   LIFE SCIENCES

Antifungal activity improved by coproduction of cyclodextrins and anabaenolysins in Cyanobacteria

(2015) Tania K. Shishido et al.   PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA

Comparative benefits and harms of second generation antidepressants and cognitive behavioral therapies in initial treatment of major depressive disorder: systematic review and meta-analysis

(2015) Halle R Amick et al.   BMJ-British Medical Journal

Antidepressant-Like Effect of the Leaves ofPseudospondias microcarpain Mice: Evidence for the Involvement of the Serotoninergic System, NMDA Receptor Complex, and Nitric Oxide Pathway

(2015) Donatus Wewura Adongo et al.   Biomed Research International

Comparative benefits and harms of second generation antidepressants and cognitive behavioral therapies in initial treatment of major depressive disorder: systematic review and meta-analysis

(2015) Halle R Amick et al.   BMJ-British Medical Journal

Collaborative Development of 2-Hydroxypropyl-β-Cyclodextrin for the Treatment of Niemann-Pick Type C1 Disease

(2014) Elizabeth Ottinger et al.   CURRENT TOPICS IN MEDICINAL CHEMISTRY

Effectiveness of community facilitator training in improving knowledge, attitudes, and confidence in relation to depression and suicidal behavior: Results of the OSPI-Europe intervention in four European countries

(2014) Evelien Coppens et al.   JOURNAL OF AFFECTIVE DISORDERS

Meta-Analysis of Molecular Imaging of Serotonin Transporters in Major Depression

(2014) Gregor Gryglewski et al.   JOURNAL OF CEREBRAL BLOOD FLOW AND METABOLISM

The Use of Flavonoids in Central Nervous System Disorders

(2013) C. Grosso et al.   CURRENT MEDICINAL CHEMISTRY

Evidence for the involvement of the monoaminergic system, but not the opioid system in the antidepressant-like activity of ellagic acid in mice

(2012) Chandrashekaran Girish et al.   EUROPEAN JOURNAL OF PHARMACOLOGY

In vivo evaluation of the highly soluble oral β-cyclodextrin–Sertraline supramolecular complexes

(2012) Joel J. Passos et al.   INTERNATIONAL JOURNAL OF PHARMACEUTICS

Cyclodextrins

(2012) Sergey V. Kurkov et al.   INTERNATIONAL JOURNAL OF PHARMACEUTICS

The antidepressant-like effect of fisetin involves the serotonergic and noradrenergic system

(2011) Linlin Zhen et al.   BEHAVIOURAL BRAIN RESEARCH

Epidemiology of chronic and nonchronic major depressive disorder: results from the national epidemiologic survey on alcohol and related conditions

(2011) Jose M. Rubio et al.   DEPRESSION AND ANXIETY

Multi-equilibrium system based on sertraline and β-cyclodextrin supramolecular complex in aqueous solution

(2011) Joel J. Passos et al.   INTERNATIONAL JOURNAL OF PHARMACEUTICS

The role of BDNF and its receptors in depression and antidepressant drug action: Reactivation of developmental plasticity

(2010) Eero Castrén et al.   Developmental Neurobiology

A review on cyclodextrin encapsulation of essential oils and volatiles

(2010) Helena Ma Cabral Marques   FLAVOUR AND FRAGRANCE JOURNAL

Dietary inhibitors of monoamine oxidase A

(2010) Sarah E. Dixon Clarke et al.   JOURNAL OF NEURAL TRANSMISSION

Pharmaceutical applications of cyclodextrins: basic science and product development

(2010) Thorsteinn Loftsson et al.   JOURNAL OF PHARMACY AND PHARMACOLOGY

A review on the use of cyclodextrins in foods

(2009) G. Astray et al.   FOOD HYDROCOLLOIDS

Managing Partial Response or Nonresponse

(2009) George I. Papakostas   JOURNAL OF CLINICAL PSYCHIATRY

Identifying Difficult-to-Treat Depression

(2009) Bradley N. Gaynes   JOURNAL OF CLINICAL PSYCHIATRY

Antidepressant-like effect of rutin isolated from the ethanolic extract from Schinus molle L. in mice: Evidence for the involvement of the serotonergic and noradrenergic systems

(2008) Daniele G. Machado et al.   EUROPEAN JOURNAL OF PHARMACOLOGY

The molecular neurobiology of depression

(2008) Vaishnav Krishnan et al.   NATURE

Propriedades e aplicações recentes das ciclodextrinas

(2008) Cristina de Garcia Venturini et al.   QUIMICA NOVA

Cyclodextrins

(2008) Valentino J. Stella et al.   TOXICOLOGIC PATHOLOGY